The European Medicines Agency says it is evaluating whether to authorise booster doses of Johnson & Johnson’s single-shot COVID-19 vaccine. In a statement Monday, the EU drug regulator said it was considering an application from J&J to recommend booster doses of the J&J vaccine for adults 18 and over, at least two months after they were first immunised.
Amid an explosive surge of new coronavirus infections across Europe, the EMA said it expected to make a decision on this within weeks.
The US Food and Drug Administration gave the green light to J&J booster doses in October, both for people who initially received the J&J and vaccine and for people who got immunised with other vaccines. J&J earlier presented results from a large study that found giving a second dose just two months after the first bumped protection against symptomatic COVID-19 to 94 per cent from 70 per cent in US recipients. Giving that booster six months later instead prompted an even bigger jump in virus-fighting antibodies.
EU countries initially ordered about 200 million doses of J&J’s vaccine, but only a fraction have been delivered after the company has faced repeated production problems.
The EMA has previously said its 27 nations could consider administering booster doses of vaccines made by Pfizer-BioNTech and Moderna for people who had received the two-dose regimens at least six months before, noting that a third shot would provide additional antibodies against COVID-19. The agency is expected to decide later this week on COVID-19 vaccines for children aged 5 to 11.
- Ayush Ministry signs MoU with Ministry of Rural Development to empower the rural youth - March 17, 2023
- Know what’s best for your ‘Kidney’ – Understand the ‘Y.’ - March 9, 2023
- KidneyHealthForAll on World Kidney Day - March 9, 2023
- COVID case rates hit new high for England, study finds - April 7, 2022
- Govt’s focus on affordable healthcare ensured significant savings for poor, middle class: PM Modi - April 7, 2022
- SRL Diagnostics and Skye Air Mobility collaborate to transport pathology samples using drone logistics - April 6, 2022
- Healthineers sets up new production line of CT scanners in Bengaluru under PLI scheme - April 6, 2022
- Lupin inks licensing pact with Alvion to market drugs in Southeast Asia - April 6, 2022
- Yoga Mahotsav: Ayush Ministry to organise event to demonstrate common yoga on World Health Day - April 6, 2022
- LordsMed forays into the medtech space with launch of health ATMs ‘Lords Sehat’ - April 5, 2022
